Effectiveness of divalproex in the treatment of disruptive behavior disorders in children: A retrospective chart review

Primary Psychiatry

Volumn 11, Issue 10, 2004, Pages 48-52

  Lehman, Robert B ^a  

^a PharmaSite Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; BUSPIRONE; CARBAMAZEPINE; CLOMIPRAMINE; CLONIDINE; DEXAMPHETAMINE; FLUOXETINE; GABAPENTIN; IMIPRAMINE; LITHIUM; METHYLPHENIDATE; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PEMOLINE; PERPHENAZINE; RISPERIDONE; SERTRALINE; VALPROATE SEMISODIUM;

ACADEMIC ACHIEVEMENT; ADOLESCENT; AGGRESSION; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIPLOPIA; DIZZINESS; DRUG EFFICACY; FATIGUE; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; LETHARGY; LEUKOPENIA; MALE; MENTAL DISEASE; OUTPATIENT CARE; POLYPHARMACY; PROSPECTIVE STUDY; RASH; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SOCIAL ASPECT; TREATMENT OUTCOME; VERBAL BEHAVIOR; VISUAL IMPAIRMENT; WEIGHT GAIN;

EID: 8444232065     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Pratt HD, Greydanus DE. Adolescent violence: concepts for a new millennium. Adolesc Med. 2000;11(1):103-125.
2. Ryan JM. Pharmacologic approach to aggression in neuropsychiatric disorders. Semin Clin Neuropsychiatry. 2000;5(4):238-249.
3. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
4. Lesesne CA, Visser SN, White CP. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources. Pediatrics. 2003;111(5 part 2):1232-1237.
5. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564-577.
6. Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry. 2000;57(7):649-654.
7. Campbell M, Adams PB, Small AM, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1995;34(4):445-453. Erratum in: J Am Acad Child Adolesc Psychiatry. 1995;34(5):694.
8. Campbell M, Adams PB, Small AM, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1995;34(4):445-453. Erratum in: J Am Acad Child Adolesc Psychiatry. 1995;34(5):694.
9. Barratt ES. The use of anticonvulsants in aggression and violence. Psychopharmacol Bull. 1993;29(1):75-81.
10. Lindenmayer JP, Kotsaftis A. Use of sodium valproate in violent and aggressive behaviors: a critical review. J Clin Psychiatry. 2000;61(2):123-128.
11. McDougle CJ, Stigler KA, Posey DJ. Treatment of aggression in children and adolescents with autism and conduct disorder. J Clin Psychiatry. 2003;64(suppl 4):16-25.
12. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull. 1992;28(2):193-199. Erratum in: Psychopharmacol Bull. 1992;28(3):220.
13. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull. 1992;28(2):193-199. Erratum in: Psychopharmacol Bull. 1992;28(3):220.
14. Cueva JE, Overall JE, Small AM, Armenteros JL, Perry R, Campbell M. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry. 1996;35(4):480-490.
15. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosivetemper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000;157(5):818-820. Erratum in: Am J Psychiatry. 2000;157(6):1038. Am J Psychiatry. 2000;157(7):1192.
16. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosivetemper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000;157(5):818-820. Erratum in: Am J Psychiatry. 2000;157(6):1038. Am J Psychiatry. 2000;157(7):1192.
17. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosivetemper and mood lability: a double-blind, placebo-controlled crossover design. Am J Psychiatry. 2000;157(5):818-820. Erratum in: Am J Psychiatry. 2000;157(6):1038. Am J Psychiatry. 2000;157(7):1192.
18. Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry. 2001;62(7):530-534.
19. Rugino TA, Samsock TC. Levetiracetam in autistic children: an open-label study. J Dev Behav Pediatr. 2002;23(4):225-230.
20. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(6):713-720.
21. Wagner KD, Weller EB, Carlson GA, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1224-1230.
22. Davanzo P, Gunderson B, Belin T, et al. Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review. Psychiatry Clin Neurosci. 2003;57(5):504-510.
23. Findling RL, McNamara NK, Gracious BL, et al. Combination lithium and divalproex sodium in pediatric bipolarity. J Am Acad Child Adolesc Psychiatry. 2003;42(8):895-901.
24. Donovan SJ, Nunes EV, Stewart JW, et al. "Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder? J Clin Psychiatry. 2003;64(6):698-701.
25. Donovan SJ, Susser ES, Nunes EV, Stewart JW, Quitkin FM, Klein DF. Divalproex treatment of disruptive adolescents: a report of 10 cases. J Clin Psychiatry. 1997;58(1):12-15.
26. Hawkins JW, Tinklenberg JR, Sheikh JI, Peyser CE, Yesavage JA. A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias. Am J Geriatr Psychiatry. 2000;8(3):221-225.
27. Wolf SM, Shinnar S, Kang H, Gil KB, Moshe SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia. 1995;36(12):1203-1205.
28. Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia. 1996;37(1):87-90.
29. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia. 1996;37(5):501-502.
30. Redenbaugh JE, Sato S, Penry JK, Dreifuss FE, Kupferberg HJ. Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures. Neurology. 1980;30(1):1-6.
31. Bruni J, Wilder BJ. Valproic acid. Review of a new antiepileptic drug. Arch Neurol. 1979;36(7):393-398.
32. Papatheodorou G, Kutcher SP. Divalproex sodium treatment in late adolescent and young adult acute mania. Psychopharmacol Bull. 1993;29(2):213-219.
33. Papatheodorou G, Kutcher SP, Katic M, Szalai JP. The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial. J Clin Psychopharmacol. 1995;15(2):110-116.